Home › Funds › Siren, L.L.C. › COGT
Siren, L.L.C. position in COGT
Cogent Biosciences, Inc. · Health Care
Siren, L.L.C. reported holding 1,609,279 shares of COGT (Cogent Biosciences, Inc.) in its Q3 2026 13F filing — a position valued at US$51.5M, representing 1.22% of its reported portfolio and ranking #25 among its reported holdings. Siren, L.L.C. has disclosed COGT holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Siren, L.L.C.'s COGT position evolved
Siren, L.L.C. first disclosed a stake in COGT in Q2 2025 at 854,379 shares (US$6.1M). The position peaked in Q2 2026 at 1,859,279 shares, worth US$72.0M. Across 6 filings, Siren, L.L.C. increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,609,279 shares valued at US$51.5M — a reduction of -250,000 shares quarter over quarter.. Notable position changes include a 102% increase in Q3 2025 (shares rose 147% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 854.38K | $6.13M | New |
| Q3 2025 | 1.72M | $24.76M | Add |
| Q4 2025 | 1.63M | $57.87M | Reduce |
| Q1 2026 | 1.71M | $65.79M | Add |
| Q2 2026 | 1.86M | $71.95M | Add |
| Q3 2026 | 1.61M | $51.53M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About COGT and 13F data
COGT (Cogent Biosciences, Inc.) is a Health Care company. 56 other funds we track also report a position in COGT — the largest reported positions include Fairmount Funds Management LLC (US$213.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$193.7M), TCG Crossover Management, LLC (US$187.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COGT
- Fairmount Funds Management LLC 5.50M sh · $212.98M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 5.01M sh · $193.74M · Q2 2026
- TCG Crossover Management, LLC 4.85M sh · $187.87M · Q2 2026
- Kynam Capital Management, LP 3.67M sh · $141.92M · Q2 2026
- Commodore Capital LP 3.05M sh · $118.03M · Q2 2026
- Octagon Capital Advisors LP 2.35M sh · $90.94M · Q2 2026
- RTW INVESTMENTS, LP 2.31M sh · $89.36M · Q2 2026
- Deep Track Capital, LP 2.00M sh · $77.40M · Q2 2026
- Venrock Adviser, LLC 1.64M sh · $63.55M · Q2 2026
- EMERALD ADVISERS, LLC 1.60M sh · $62.05M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 1.28M sh · $49.56M · Q2 2026
- Elmind Capital, LP 1.17M sh · $45.31M · Q2 2026
More on Siren, L.L.C.
FAQ
How long has Siren, L.L.C. held COGT?
Siren, L.L.C. has disclosed COGT holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Siren, L.L.C.'s current position in COGT?
As of Q3 2026, Siren, L.L.C. holds 1.61M shares of COGT (Cogent Biosciences, Inc.), valued at $51.53M, representing 1.22% of its reported portfolio and ranking #25.
Has Siren, L.L.C. been buying or selling COGT?
In the latest 13F filing (Q3 2026), Siren, L.L.C. reduced its position in COGT. The position peaked in Q2 2026 at 1.86M shares.
Which other funds hold COGT?
Other major institutional holders of COGT include Fairmount Funds Management LLC, DEERFIELD MANAGEMENT COMPANY, L.P., TCG Crossover Management, LLC, among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.